Bortezomib Zentiva 3.5 mg, Lyophilisat zur Herstellung einer Injektionslösung
7680683440022
CH-68344
L01XG01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6834402
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- bortezomibum 3.5 mg, mannitolum, pro vitro.
Articles (1)
Bortezomib Zentiva 3.5 mg, Lyophilisat zur Herstellung einer Injektionslösung
Lyophilisat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bortezomibum
|
3.5 MG | Substance | Wirkstoff (Principe actif) |
|
mannitolum
|
- | Substance | HNIDK |
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68344
- Drug name
- Bortezomib Zentiva, Lyophilisat zur Herstellung einer Injektionslösung
- Galenic form
- LSINL
- ATC Code
- L01XG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/08/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BORTEZOMIB Zentiva subst sèche 3.5 mg flac
- Description (DE)
- BORTEZOMIB Zentiva Trockensub 3.5 mg Durchstf
- Market launch
- 05/08/2021
- Market withdrawal
- 24/06/2026
- Narcotic (BTM)
- No